Genrinho, I., Ferreira, P. L., Santiago, T., Carones, A., Mazeda, C., Barcelos, A., Beirão, T., Costa, F., Santos, I., Couto, M., Rato, M., Terroso, G., & Monteiro, P. (2023). Validation of the Portuguese Version of the Scleroderma Health Assessment Questionnaire. International journal of environmental research and public health, 20(22), 7062. https://doi.org/10.3390/ijerph20227062 Mapi Research Trust. (n.d.). Scleroderma Health Assessment Questionnaire. ePROVIDE. https://eprovide.mapi-trust.org/instruments/scleroderma-health-assessment-questionnaire Merkel, P. A., Herlin, K., Martin, R. W., et al. for the Scleroderma Clinical Trials Consortium. (2002). Measuring disease activity and functional status in patients with scleroderma and Raynaud’s Phenomenon. Arthritis & Rheumatism, 46(9), 2410-2420. https://doi.org/10.1002/art.10486 Smyth, A. E., MacGregor, A. J., Mukerjee, D., Brough, G. M., Black, C. M., & Denton, C. P. (2003). A cross-sectional comparison of three self-reported functional indices in scleroderma. Rheumatology, 42(6), 732-738. https://doi.org/10.1093/rheumatology/keg145 Steen, V. D., & Medsger, T. A., Jr. (1997). The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time. Arthritis and Rheumatism, 40(11), 1984–1991. https://doi.org/10.1002/art.1780401110 |